376
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Decreased Sigmoidal ABCB1 (P-Glycoprotein) Expression in Ulcerative Colitis is Associated with Disease Activity

, , , , , , , , , & show all
Pages 1941-1953 | Published online: 03 Dec 2009

Bibliography

  • Xavier RJ , PodolskyDK: Unravelling the pathogenesis of inflammatory bowel disease.Nature448 , 427–434 (2007).
  • Sharom FJ : ABC multidrug transporters: structure, function and role in chemoresistance.Pharmacogenomics9 , 105–127 (2008).
  • Ho GT , MoodieFM, SatsangiJ: Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?Gut52 , 759–766 (2003).
  • Gros P , CroopJ, HousmanD: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.Cell47 , 371–380 (1986).
  • Panwala CM , JonesJC, VineyJL: A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis.J. Immunol.161 , 5733–5744 (1998).
  • Glaeser H , BaileyDG, DresserGK et al.: Intestinal drug transporter expression and the impact of grapefruit juice in humans.Clin. Pharmacol. Ther.81 , 362–370 (2007).
  • Kotka M , LiedenA, PetterssonS, TrinchieriV, MasciA, D‘AmatoM: Solute carriers (SLC) in inflammatory bowel disease: a potential target of probiotics?J. Clin. Gastroenterol.42(Suppl. 3, Pt 1) , S133–S135 (2008).
  • Paine MF , HartHL, LudingtonSS, HainingRL, RettieAE, ZeldinDC: The human intestinal cytochrome P450 ‘pie‘.Drug Metab. Dispos.34 , 880–886 (2006).
  • Thorn M , FinnstromN, LundgrenS, RaneA, LoofL: Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract.Br. J. Clin. Pharmacol.60 , 54–60 (2005).
  • Zhang Y , BenetLZ: The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.Clin. Pharmacokinet.40 , 159–168 (2001).
  • Hickman D , PopeJ, PatilSD et al.: Expression of arylamine N-acetyltransferase in human intestine.Gut42 , 402–409 (1998).
  • Morgan ET , GoralskiKB, Piquette-MillerM et al.: Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer.Drug Metab. Dispos.36 , 205–216 (2008).
  • Bertilsson PM , OlssonP, MagnussonKE: Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells.J. Pharm. Sci.90 , 638–646 (2001).
  • Belliard AM , LacourB, FarinottiR, LeroyC: Effect of tumor necrosis factor-α and interferon-γ on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells.J. Pharm. Sci.93 , 1524–1536 (2004).
  • Blokzijl H , Vander Borght S, Bok LI et al.: Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm. Bowel Dis.13 , 710–720 (2007).
  • Englund G , JacobsonA, RorsmanF, ArturssonP, KindmarkA, RonnblomA: Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).Inflamm. Bowel Dis.13 , 291–297 (2007).
  • Wang H , LeCluyseEL: Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.Clin. Pharmacokinet.42 , 1331–1357 (2003).
  • Willson TM , KliewerSA: PXR, CAR and drug metabolism.Nat. Rev. Drug Discov.1 , 259–266 (2002).
  • Geick A , EichelbaumM, BurkO: Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin.J. Biol. Chem.276 , 14581–14587 (2001).
  • Burk O , KochI, RaucyJ et al.: The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR).J. Biol. Chem.279 , 38379–38385 (2004).
  • Langmann T , MoehleC, MauererR et al.: Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes.Gastroenterology127 , 26–40 (2004).
  • Lim YP , HuangJD: Interplay of pregnane X receptor with other nuclear receptors on gene regulation.Drug Metab. Pharmacokinet.23 , 14–21 (2008).
  • Combates NJ , RzepkaRW, ChenYN, CohenD: NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter.J. Biol. Chem.269 , 29715–29719 (1994).
  • Zhou C , TabbMM, NelsonEL et al.: Mutual repression between steroid and xenobiotic receptor and NF-κB signaling pathways links xenobiotic metabolism and inflammation.J. Clin. Invest.116 , 2280–2289 (2006).
  • Mohan M , AyePP, BordaJT, AlvarezX, LacknerAA: CCAAT/enhancer binding protein β is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaques.Am. J. Pathol.173 , 106–118 (2008).
  • Atreya I , AtreyaR, NeurathMF: NF-κB in inflammatory bowel disease.J. Intern. Med.263 , 591–596 (2008).
  • Cascorbi I : Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.Pharmacol. Ther.112 , 457–473 (2006).
  • Hoffmeyer S , BurkO, von Richter O et al.: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA97 , 3473–3478 (2000).
  • Kimchi-Sarfaty C , OhJM, KimIW et al.: A ‘silent‘ polymorphism in the MDR1 gene changes substrate specificity.Science315 , 525–528 (2007).
  • Lamba JK , LinYS, ThummelK et al.: Common allelic variants of cytochrome P4503A4 and their prevalence in different populations.Pharmacogenetics12 , 121–132 (2002).
  • Kuehl P , ZhangJ, LinY et al.: Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.Nat. Genet.27 , 383–391 (2001).
  • Costello CM , MahN, HaslerR et al.: Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.PLoS Med.2 , E199 (2005).
  • Seo M , OkadaM, MaedaK, OhK: Correlation between endoscopic severity and the clinical activity index in ulcerative colitis.Am. J. Gastroenterol.93 , 2124–2129 (1998).
  • Walmsley RS , AyresRC, PounderRE, AllanRN: A simple clinical colitis activity index.Gut43 , 29–32 (1998).
  • Ufer M , DilgerK, LeschhornL et al.: Influence of CYP3A4, CYP3A5, and ABCB1 genotype and expression on budesonide pharmacokinetics: a possible role of intestinal CYP3A4 expression.Clin. Pharmacol. Ther.84 , 43–46 (2008).
  • Murakami T , TakanoM: Intestinal efflux transporters and drug absorption.Expert Opin. Drug Metab. Toxicol.4 , 923–939 (2008).
  • Ashburner M , BallCA, BlakeJA et al.: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.Nat. Genet.25 , 25–29 (2000).
  • Vandesompele J , De Preter K, Pattyn F et al.: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol.3(7) , RESEARCH0034 (2002).
  • Livak KJ , SchmittgenTD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-D D C(T)) method.Methods25 , 402–408 (2001).
  • Bradford MM : A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal. Biochem.72 , 248–254 (1976).
  • Benjamini Y , HochbergY: Controlling the false discovery rate: a practical and powerful approach to multiple testing.J. R. Statist. Soc. B.57 , 289–300 (1995).
  • Leslie EM , DeeleyRG, ColeSP: Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.Toxicol. Appl. Pharmacol.204 , 216–237 (2005).
  • Stein U , WaltherW, ShoemakerRH: Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance.Br. J. Cancer74 , 1384–1391 (1996).
  • Ho EA , Piquette-MillerM: Regulation of multidrug resistance by pro-inflammatory cytokines.Curr. Cancer Drug. Targets6 , 295–311 (2006).
  • Burk O , ArnoldKA, GeickA, TegudeH, EichelbaumM: A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression.Biol. Chem.386 , 503–513 (2005).
  • Zimmerman TL , ThevanantherS, GhoseR, BurnsAR, KarpenSJ: Nuclear export of retinoid X receptor α in response to interleukin-1β-mediated cell signaling: roles for JNK and SER260.J. Biol. Chem.281 , 15434–15440 (2006).
  • Matsuda R , KoideT, TokoroC et al.: Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naive ulcerative colitis during active and quiescent disease.Inflamm. Bowel Dis.15 , 328–334 (2009).
  • Daig R , AndusT, AschenbrennerE, FalkW, ScholmerichJ, GrossV: Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.Gut38 , 216–222 (1996).
  • Walther W , SteinU: Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs.J. Cancer Res. Clin. Oncol.120 , 471–478 (1994).
  • Fantini MC , PalloneF: Cytokines: from gut inflammation to colorectal cancer.Curr. Drug Targets9 , 375–380 (2008).
  • Cascorbi I , BrockmollerJ, MrozikiewiczPM, MullerA, RootsI: Arylamine N-acetyltransferase activity in man.Drug Metab. Rev.31 , 489–502 (1999).
  • Meyer-Hoffert U , HornefMW, Henriques-NormarkB et al.: Secreted enteric antimicrobial activity localises to the mucus surface layer.Gut57 , 764–771 (2008).
  • Wehkamp J , SchwindB, HerrlingerKR et al.: Innate immunity and colonic inflammation: enhanced expression of epithelial α-defensins.Dig. Dis. Sci.47 , 1349–1355 (2002).
  • Noble CL , AbbasAR, CorneliusJ et al.: Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis.Gut57 , 1398–1405 (2008).
  • Schwab M , SchaeffelerE, MarxC et al.: Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.Gastroenterology124 , 26–33 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.